Table 3. Pairwise Comparisons of PET Semi-Quantitatively Parameters between Different Subgroups.
Subgroups | SUVmax | BSV | BSL | |||
---|---|---|---|---|---|---|
Mean | P | Mean | P | Mean | P | |
AIS vs. MIA | 1.0 vs. 1.9 | 0.001 | 1.6 vs. 4.5 | < 0.001 | 2.1 vs. 6.9 | < 0.001 |
AIS vs. IA | 1.0 vs. 6.8 | 0.000 | 1.6 vs. 10.9 | < 0.001 | 2.1 vs. 37.8 | < 0.001 |
MIA vs. IA | 1.9 vs. 6.8 | 0.000 | 4.5 vs. 10.9 | < 0.001 | 6.9 vs. 37.8 | < 0.001 |
AIS vs. L | 1.0 vs. 3.7 | 0.000 | 1.6 vs. 10.5 | < 0.001 | 2.1 vs. 18.9 | < 0.001 |
MIA vs. L | 1.9 vs. 3.7 | 0.005 | 4.5 vs. 10.5 | < 0.001 | 6.9 vs. 18.9 | 0.005 |
M vs. S | 13.1 vs. 11.3 | 0.413 | 14.3 vs. 9.7 | 0.907 | 106.1 vs. 63.2 | 0.516 |
L vs. A | 3.7 vs. 6.9 | 0.000 | 10.5 vs. 9.0 | 0.073 | 18.9 vs. 29.0 | 0.015 |
L vs. P | 3.7 vs. 5.3 | 0.059 | 10.5 vs. 25.7 | 0.005 | 18.9 vs. 67.3 | < 0.001 |
L vs. S + M | 3.7 vs. 11.7 | 0.000 | 10.5 vs. 13.4 | 0.038 | 18.9 vs. 97.1 | < 0.001 |
L vs. V | 3.7 vs. 7.9 | 0.000 | 10.5 vs. 30.9 | 0.019 | 18.9 vs. 209.9 | < 0.001 |
A vs. P | 6.9 vs. 5.3 | 0.107 | 9.0 vs. 12.3 | < 0.001 | 29.0 vs. 67.3 | 0.003 |
A vs. S + M | 6.9 vs. 11.7 | 0.000 | 9.0 vs. 13.4 | 0.008 | 29.0 vs. 97.1 | < 0.001 |
A vs. V | 6.9 vs. 7.9 | 0.231 | 9.0 vs. 30.9 | < 0.001 | 29.0 vs. 209.9 | 0.002 |
P vs. S + M | 5.3 vs. 11.7 | 0.000 | 25.7 vs. 13.4 | 0.385 | 67.3 vs. 97.1 | 0.932 |
P vs. V | 5.3 vs. 7.9 | 0.052 | 25.7 vs. 30.9 | 0.433 | 67.3 vs. 209.9 | 0.689 |
S + M vs. V | 11.7 vs. 7.9 | 0.004 | 13.4 vs. 30.9 | 0.066 | 97.1 vs. 209.9 | 0.713 |
A = acinar predominant adenocarcinoma, AIS = adenocarcinoma in situ, BSL = background subtracted lesion activity, BSV = background subtracted volume, L = lepidic predominant adenocarcinoma, M = micropapillary adenocarcinoma, MIA = minimally invasive adenocarcinoma, P = papillary predominant adenocarcinoma, S = solid predominant adenocarcinoma, SUVmax = maximum standardized uptake value, S + M = solid predominant and micropapillary adenocarcinoma, V = variant adenocarcinoma